Methysergide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00247 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 96 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | migraine with or without aura, susceptibility to | KG + DL |
| 4 | atrophoderma vermiculata | KG + DL |
| 5 | ulerythema ophryogenesis | KG + DL |
| 6 | pulmonary hypertension | KG + DL |
| 7 | kyphoscoliotic heart disease | KG + DL |
| 8 | dysthymic disorder | KG + DL |
| 9 | hypertrichosis (disease) | KG + DL |
| 10 | amenorrhea (disease) | KG + DL |
| 11 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 12 | sciatic neuropathy | KG + DL |
| 13 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 14 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 15 | isolated genetic hair shaft abnormality | KG + DL |
| 16 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 17 | tendinitis | KG + DL |
| 18 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 19 | erectile dysfunction (disease) | KG + DL |
| 20 | coxopodopatellar syndrome | KG + DL |
| 21 | fibromyalgia | KG + DL |
| 22 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 23 | myositis fibrosa | KG + DL |
| 24 | idiopathic granulomatous myositis | KG + DL |
| 25 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 26 | idiopathic pulmonary arterial hypertension | KG + DL |
| 27 | Tourette syndrome | KG + DL |
| 28 | pulmonary hypertension, primary | KG + DL |
| 29 | headache disorder | KG + DL |
| 30 | inclusion body myositis | KG + DL |
| 31 | neurotic disorder | KG + DL |
| 32 | idiopathic and/or familial pulmonary arterial hypertension | KG + DL |
| 33 | mycotic corneal ulcer | KG + DL |
| 34 | peripheral arterial disease | KG + DL |
| 35 | gastrointestinal hamartoma | KG + DL |
| 36 | trichotillomania | KG + DL |
| 37 | endogenous depression | KG + DL |
| 38 | Ohdo syndrome and variants | KG + DL |
| 39 | benign prostatic hyperplasia (disease) | KG + DL |
| 40 | Prinzmetal angina | KG + DL |
| 41 | neuroblastoma | KG + DL |
| 42 | peripheral vascular disease | KG + DL |
| 43 | heritable pulmonary arterial hypertension | KG + DL |
| 44 | intermittent vascular claudication | KG + DL |
| 45 | trigeminal autonomic cephalalgia | KG + DL |
| 46 | neurotic depression | KG + DL |
| 47 | melancholia | KG + DL |
| 48 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 49 | congenital isolated adrenocorticotropic hormone deficiency (disease) | KG + DL |
| 50 | pulmonary arterial hypertension | KG + DL |
(Showing top 50 of 96 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.